STOCK TITAN

ROCKET PHARMACEUTICALS Stock Price, News & Analysis

RCKTW NASDAQ

Company Description

Welcome to the overview page for ROCKET PHARMACEUTICALS (RCKTW), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
-62.91%
Performance 1 year

Latest News

No recent news available for ROCKET PHARMACEUTICALS.

Financial Highlights

$0
Revenue (TTM)
-$258.7M
Net Income (TTM)
-$209.7M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in ROCKET PHARMACEUTICALS (RCKTW) currently stands at 4.4 thousand shares, down 12.0% from the previous reporting period. Over the past 12 months, short interest has increased by 56.3%.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for ROCKET PHARMACEUTICALS (RCKTW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.8 days.

Frequently Asked Questions

What is the current stock price of ROCKET PHARMACEUTICALS (RCKTW)?

The current stock price of ROCKET PHARMACEUTICALS (RCKTW) is $0.0257 as of February 26, 2026.

What is the revenue (TTM) of ROCKET PHARMACEUTICALS (RCKTW) stock?

The trailing twelve months (TTM) revenue of ROCKET PHARMACEUTICALS (RCKTW) is $0.

What is the net income of ROCKET PHARMACEUTICALS (RCKTW)?

The trailing twelve months (TTM) net income of ROCKET PHARMACEUTICALS (RCKTW) is -$258.7M.

What is the earnings per share (EPS) of ROCKET PHARMACEUTICALS (RCKTW)?

The diluted earnings per share (EPS) of ROCKET PHARMACEUTICALS (RCKTW) is $-2.73 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of ROCKET PHARMACEUTICALS (RCKTW)?

The operating cash flow of ROCKET PHARMACEUTICALS (RCKTW) is -$209.7M. Learn about cash flow.

What is the current ratio of ROCKET PHARMACEUTICALS (RCKTW)?

The current ratio of ROCKET PHARMACEUTICALS (RCKTW) is 9.30, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of ROCKET PHARMACEUTICALS (RCKTW)?

The operating income of ROCKET PHARMACEUTICALS (RCKTW) is -$273.2M. Learn about operating income.